Freelite®

The majority of myeloma patients produce excess FLCs which can be nephrotoxic.

Freelite assays offer rapid initial aid to detect myeloma kidney in patients with unexplained Acute Kidney Injury (AKI)

The increased sensitivity of Freelite assays support early diagnosis of myeloma kidney patients

The International Kidney and Monoclonal Gammopathy Research Group recommend the use of this algorithm for new unexplained AKI: